Zhang Hui, Xu Caiyuan, Zhang Tongxing, Gao Zhongyu, Zhang Tao
Department of Anesthesiology, First Central Clinical College of Tianjin Medical University, Dept. of Orthopedic Surgery, Tianjin, China.
Pain Physician. 2017 Jan-Feb;20(1):E13-E28.
Because of an aging population,osteoporotic vertebral fractures are becoming more frequent.Conservative therapy was considered the gold standard for treating osteoporotic vertebral compression fractures (OVCFs) in the past. Percutaneous vertebroplasty (PVP) or balloon kyphoplasty (BKP) as minimally invasive techniques are new treatments that are widely used for painful OVCFs. However, an increase in new vertebral compression fractures at non-treated levels following augmentation is of concern. There is no convincing evidence that new fractures are inevitable after augmentation compared to after conservative treatment, and it is still unclear whether further fractures are the consequence of augmentation or a result of the natural progression of osteoporosis.
The objective of this study was to evaluate the new-level fracture risk after PVP or BKP compared with conservative (non-operative) treatment and to determine the dominant risk factor associated with new OVCFs.
A meta-analysis of comparative studies was performed to evaluate the incidence of new vertebral fractures between vertebral augmentation, such as vertebroplasty and kyphoplasty, and no operation.
The PubMed, ISI Web of Science, ELSEVIER ScienceDirect, and Cochrane Library databases and abstracts published in annual proceedings were systematically searched.In addition, we also retrieved data from references when titles met our inclusion criteria.
Detailed searches of a number of online databases comparing operative and non-operative groups were performed. We included randomized controlled trials,clinical controlled trials,and prospective clinical studies to provide available data. All studies were reviewed by two reviewers independently, and all the references that met our inclusion criteria were searched for additional trials, using the guidelines set by the QUOROM (Quality of Reporting of Meta-analysis) statement.
We evaluated 12 studies encompassing 1,328 patients in total, including 768 who underwent operation with polymethylmethacrylateand 560 who received non-operative treatments. For new-level vertebral fractures, our meta-analysis found no significant difference between the 2 methods, including total new fractures (P = 0.55) and adjacent fractures (P = 0.5). For pre-existing vertebral fractures, there was no significant difference between the 2 groups (operative and non-operative groups) (P = 0.24). Additionally,there was no significant difference in bone mineral density, both in the lumbar (P = 0 .13) and femoral neck regions (P = 0.37), between the 2 interventions.
All studies we screened were published online except for unpublished articles. Moreover, only a few data sources could be extracted from the published studies.There were only 5 randomized clinical trials and 7 prospective studies that met our inclusion criteria.
Vertebral augmentation techniques, such as vertebroplasty and kyphoplasty, have been widely used to treat osteoporotic vertebral fractures in order to alleviate back pain and correct the deformity, and it has been frequently reported that many new vertebral fractures occurred after this operation. Our analysis did not reveal evidence of an increased risk of fracture of vertebral bodies, especially those adjacent to the treated vertebrae, following augmentation with either method compared with conservative treatment.Key words: Vertebroplasty, kyphoplasty, new osteoporotic compression vertebral fracture, meta-analysis.
由于人口老龄化,骨质疏松性椎体骨折日益常见。过去,保守治疗被视为治疗骨质疏松性椎体压缩骨折(OVCFs)的金标准。经皮椎体成形术(PVP)或球囊扩张椎体后凸成形术(BKP)作为微创技术,是广泛用于治疗疼痛性OVCFs的新疗法。然而,强化治疗后未治疗节段出现新的椎体压缩骨折令人担忧。与保守治疗相比,尚无令人信服的证据表明强化治疗后新骨折不可避免,目前仍不清楚进一步骨折是强化治疗的后果还是骨质疏松自然进展的结果。
本研究旨在评估PVP或BKP与保守(非手术)治疗相比后新发骨折的风险,并确定与新发OVCFs相关的主要危险因素。
进行一项比较研究的荟萃分析,以评估椎体强化术(如椎体成形术和后凸成形术)与未手术治疗之间新发椎体骨折的发生率。
系统检索了PubMed、ISI Web of Science、ELSEVIER ScienceDirect和Cochrane图书馆数据库以及年度会议论文集中发表的摘要。此外,当标题符合纳入标准时,我们还从参考文献中检索数据。
对多个比较手术组和非手术组的在线数据库进行详细检索。我们纳入随机对照试验、临床对照试验和前瞻性临床研究以提供可用数据。所有研究均由两名审阅者独立审查,并根据QUOROM(荟萃分析报告质量)声明设定的指南,对所有符合纳入标准的参考文献进行检索以寻找其他试验。
我们评估了12项研究,共纳入1328例患者,其中768例行聚甲基丙烯酸甲酯手术治疗,560例接受非手术治疗。对于新发椎体骨折,我们的荟萃分析发现两种方法之间无显著差异,包括总的新发骨折(P = 0.55)和相邻骨折(P = 0.5)。对于既往椎体骨折,两组(手术组和非手术组)之间无显著差异(P = 0.24)。此外,两种干预措施在腰椎(P = 0.13)和股骨颈区域(P = 0.37)的骨密度方面也无显著差异。
除未发表的文章外,我们筛选的所有研究均在线发表。此外,仅能从已发表的研究中提取少数数据源。符合我们纳入标准的仅有5项随机临床试验和7项前瞻性研究。
椎体强化技术,如椎体成形术和后凸成形术,已广泛用于治疗骨质疏松性椎体骨折以缓解背痛和纠正畸形,且经常有报道称该手术后出现许多新的椎体骨折。我们的分析未发现证据表明与保守治疗相比,两种方法强化治疗后椎体骨折风险增加,尤其是治疗椎体相邻椎体的骨折风险增加。关键词:椎体成形术;后凸成形术;新发骨质疏松性压缩椎体骨折;荟萃分析